1Gisslinger H, Kurzrock R, Wtzler M,et al. Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences.Leuk Lymphoma 1997;25:121
2Daley GO, Ben Neriah Y. Implicating the bcr/ab1 in the pathogenesis of Ph+humanleukemia. Adv Cancer Res 1991;57:151
3Rostiv, Bergamaschi G, Ponchio L, et al. c-ab1 function in normal and chronicmyelogenous leukemia hematopoiesis:in vitro studies with antisense oligomers. Leukemia1992;6:1
4Fialkow JP, Martin PJ, Najfeld V, et al. Evidence for multistep pathogenesis ofchronic myelogenous leukemia. Blood 1981;58:158
5Sram K, Heisterkamp N, Grosveld, et al. Evidence of a new chimneric bcr/ab1 mRNA inpatients with chronic myelogenous leukemia and the Philadelphia chromosome. N Engl J Med1985;313:1429
6Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia inmice by the P210 bcr/ab1 gene of the Philadelphia chromosome. Science 1990;247:824
7Gisslinger H, Kurzrock R, Wetzler M, et al. Apotosis in chronic myelogenousleukemia: studies of stage-specific differences. Leuk Lymphoma 1997;25:121
8De Fabritiis P, Skorski T, De Propris MS, et al. Effect of bcr/ab1oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukemia cells.Leukemia 1997;11:811
9Preti HA,O'Brien S,Giralt S,et al. Philadelphia chromosome positive adult acutelymphocytic leukemia: characteristics, treatment result, and prognosis in 41 patients. AmJ Med 1994;97:60
10The Group Franais de Cytogenetique Hematologique.Cytogenetic abnormalities inadult acute lymphoblastic leukemia: correlation with hematologic ficings and outcome.Blood 1996;87:3135
